advertisement
11.3.4 Betablocker (7)
Showing records 1 to 7
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker11784 Change in corneal permeability to timolol after laser in situ keratomileusis and photorefractive keratectomy in rabbit
Hamada N; Amano S; Yamagami S; Araie M; Oshika T; Wada T; Miyai H; Notsu Y
Japanese Journal of Ophthalmology 2005; 49: 12-14
12096 Comparison of the efficacy and safety of dorzolamide 2% when added to brimonidine 0.2% or timolol maleate 0.5% in patients with primary open-angle glaucoma
Ozturk F; Ermis SS; Inan UU; Asagidag A; Yaman S
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 68-74
11977 Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension
Sharpe ED; Henry CJ; Mundorf TK; Day DG; Stewart JA; Jenkins JN; Stewart WC
Eye 2005; 19: 35-40
11759 Bronchial reactivity in healthy individuals undergoing long-term topical treatment with beta-blockers
Gandolfi SA; Chetta A; Cimino L; Mora P; Sangermani C; Tardini MG
Archives of Ophthalmology 2005; 123: 35-38
11886 The effects on the intraocular pressure and visual field resulting from a switch in the treatment from timolol to betaxolol
Miki H; Miki K
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 509-517
11973 Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model
Seki M; Tanaka T; Matsuda H; Togano T; Hashimoto K; Ueda J; Fukuchi T; Abe H
British Journal of Ophthalmology 2005; 89: 504-507
12097 Comparison of the effects of bimatoprost and timolol on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: A prospective, open-label, randomized, two-arm, parallel-group study
Vetrugno M; Cardascia N; Cantatore F; Sborgia C
Current Therapeutic Research - Clinical and Experimental 2004; 65: 444-454